TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Encounter Shandong: A cultural journey across borders
- 'Chicken steak brother' turns small city into instant hit
- Curtain comes down on Shanghai's popular tourism festival
- Local team effort enables evacuation of hikers from Qomolangma
- Mainland slams Taiwan leader's separatist narrative
- China, Malaysia to hold joint military drill
